Perspectives on vaccines against varicella-zoster virus infections

Current Topics in Microbiology and Immunology

Volumn 342, Issue 1, 2010, Pages 359-372

  Gershon, Anne A ^a   Gershon, Michael D ^a  

^a College of Physicians ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE; HERPES VACCINE;

CHICKENPOX; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FEVER; HERPES ZOSTER; HUMAN; LOW DRUG DOSE; MALAISE; MENINGITIS; NONHUMAN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; REVIEW; SENSORY GANGLION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS LATENCY; VIRUS REACTIVATION; ARTICLE; IMMUNOLOGY; METHODOLOGY; VIROLOGY;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

CHICKENPOX; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HERPESVIRUS VACCINES; HUMANS; VACCINATION;

EID: 79952056018     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-12     Document Type: Review

References (69)

1. Amlie-Lefond C, Jubelt B (2009) Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep 9:430-434
2. Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A (2002) Persistence of immunity to live attenuated varicella vaccine in healthy adults. Clin Infect Dis 34:774-779 (Pubitemid 34194847)
3. Arvin AM, Cohen J (2007) Varicella-zoster virus. In: Knipe DM, Howley PM (eds) Virology, 5th edn. Raven, NY, Philadelphia, pp 2773-2818
4. Berger R, Florent G, Just M (1981) Decrease of the lympho-proliferative response to varicellazoster virus antigen in the aged. Infect Immun 32:24-27 (Pubitemid 11156896)
5. Brisson M, Edmunds WJ, Gay NJ (2003) Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70(Suppl 1):S31-37 (Pubitemid 36368842)
6. Brunell PA (2000) Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics 106:e28-e29
7. Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ (1982) Immune responses to varicella-zoster in the aged. Arch Intern Med 142:291-293 (Pubitemid 12180803)
8. Centers-for-Disease-Control (2007) Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). MMWR 56:1-40
9. Centers-for-Disease-Control (2007) Prevention of varicella. MMWR 56:1-55
10. Centers-for-Disease-Control (2008) Update: recommendations from the advisory committee on immunization practices (ACIP) regarding administration of combination MMRV vaccine. MMWR 57:258-260
11. Chaves SS, Gargiullo P, Zhang JX et al (2007) Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356:1121-1129 (Pubitemid 46425596)
12. Chaves SS, Haber P, Walton K et al (2008) Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 197(Suppl 2):S170-S177 (Pubitemid 351590167)
13. Chen J, Gershon A, Silverstein SJ, Li ZS, Lungu O, Gershon MD (2003) Latent and lytic infection of isolated guinea pig enteric and dorsal root ganglia by varicella zoster virus. J Med Virol 70:S71-S78 (Pubitemid 36368850)
14. Cinque P, Bossolasco S, Vago L et al (1997) Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis 25:634-639 (Pubitemid 27392605)
15. Civen R, Chaves SS, Jumaan A et al (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28:954-959
16. ClinicalTrial.gov (2009) Immunogenicity and safety study of GSK biologicals' herpes zoster vaccine with various formulations in adults-50 years
17. ClinicalTrial.gov (2009) Safety and immunogenicity of the zoster vaccine GSK1437173A in elderly subjects
18. Feldman S, Lott L (1987) Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 80:465-472 (Pubitemid 17139665)
19. Feldman S, Hughes W, Daniel C (1975) Varicella in children with cancer: 77 cases. Pediatrics 80:388-397
20. Galea SA, Sweet A, Beninger P et al (2008) The safety profile of varicella vaccine: a 10-year review. J Infect Dis 197(Suppl 2):S165-S169 (Pubitemid 351590166)
21. Gershon AA, Steinberg S, Gelb L, NIAID-Collaborative-Varicella-Vaccine- Study-Group (1984) Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 252:355-362 (Pubitemid 14084794)
22. Gershon A, LaRussa P, Steinberg S (1996) Varicella vaccine: use in immunocompromised patients. In: White J, Ellis R (eds) Infectious disease clinics of North America, vol 10. Saunders, Philadelphia, pp 583-594
23. Gershon AA, Arvin AM, Shapiro E (2007) Varicella vaccine. N Engl J Med 356:2648-2649
24. Gershon A, Chen J, LaRussa P, Steinberg S (2007b) Varicella-zoster virus. In: Murray PR, Baron E, Jorgensen J, Landry M, Pfaller M (eds) Manual of Clinical Microbiology, 9th edn. ASM, Washington, DC, pp 1537-1548
25. Gershon AA, Chen J, Gershon MD (2008a) A model of lytic, latent, and reactivating varicellazoster virus infections in isolated enteric neurons. J Infect Dis 197(Suppl 2):S61-S65 (Pubitemid 351590148)
26. Gershon A, Takahashi M, Seward J (2008b) Live attenuated varicella vaccine. In: Plotkin S, Orenstein W, Offit P (eds) Vaccines, 5th edn. WB Saunders, Philadelphia, pp 915-958
27. Gershon AA, Levin MJ, Weinberg A et al (2009a) A Phase I-Ii study of live attenuated varicellazoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J 28:653-655
28. Gershon AA, Chen J, Davis L, Krinsky C, Cowles R, Gershon MD (2009) Distribution of latent varicella zoster virus in sensory ganglia and gut after vaccination and wild-type infection: evidence for viremic spread. In: 34th International Herpesvirus Workshop, Ithaca, NY
29. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahaliingham R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342:635-645 (Pubitemid 30118417)
30. Gould PL, Leung J, Scott C et al (2009) An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients-Arkansas, 2006. Pediatr Infect Dis J 28:678-681
31. Hardy IB, Gershon A, Steinberg S, LaRussa P et al (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 325:1545-1550
32. Hata A, Asanuma H, Rinki M et al (2002) Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347:26-34 (Pubitemid 34728954)
33. Hay J, Ruyechan WT (1994) Varicella-zoster virus: a different kind of herpesvirus latency? Semin Virol 5:241-248
34. Hope-Simpson RE (1965) The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 58:9-20
35. Iyer S, Mittal MK, Hodinka RL (2009) Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med 53:792-795
36. Jacobsen SJ, Ackerson BK, Sy LS et al (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27(34):4656-4661
37. Jean-Philippe P, Freedman A, Chang MW et al (2007) Severe varicella caused by varicellavaccine strain in a child with significant T-cell dysfunction. Pediatrics 120:e1345-e1349 (Pubitemid 350085577)
38. Jones L, Black AP, Malavige GN, Ogg GS (2006) Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection. J Virol 80:9772-9778 (Pubitemid 44435651)
39. Jones L, Black AP, Malavige GN, Ogg GS (2007) Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus. Eur J Immunol 37:3393-3403
40. Klein NP, Fireman B, Enright A, Ray P, Black S, Dekker CL (2007) A Role for Genetics in the Immune Response to the Varicella Vaccine. Pediatr Infect Dis J 26:300-305 (Pubitemid 46596652)
41. Kuter B, Matthews H, Shinefield H et al (2004) Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23:132-137 (Pubitemid 38222785)
42. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S (1992) Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66:1016-1020
43. Levin MJ (2001) Use of varicella vaccines to prevent herpes zoster in older individuals. Arch Virol (Suppl 17):151-160 (Pubitemid 33760027)
44. Levin MJ (2008) Zoster vaccine. In: Plotkin S, Orenstein W, Offit PA (eds) Vaccines, 5th edn. WB Saunderws, Philadelphia, pp 1057-1068
45. Levin MJ, Gershon AA, Weinberg A et al (2001) Immunization of HIV-infected children with varicella vaccine. J Pediatr 139:305-310 (Pubitemid 32721722)
46. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A (2003) Development of resistance to acyclovir during chronic Oka strain varicella-zoster virus infection in an immunocompromised child. J Infect Dis 188:954-959 (Pubitemid 37268243)
47. Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B (2006) Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 194:247-255 (Pubitemid 44087197)
48. Levin MJ, DeBiasi RL, Bostik V, Schmid DS (2008) Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis 198:1444-1447
49. Levy O, Orange JS, Hibberd P et al (2003) Disseminated varicella infection due to vaccine (Oka) strain varicella-zoster virus in a patient with a novel deficiency in natural killer cells. J Infect Dis 188:948-953 (Pubitemid 37268242)
50. Mehta SK, Cohrs RJ, Forghani B, Zerbe G, Gilden DH, Pierson DL (2004) Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 72:174-179 (Pubitemid 37484760)
51. Michalik DE, Steinberg SP, LaRussa PS et al (2008) Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis 197:944-949 (Pubitemid 351590021)
52. Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352:450-458 (Pubitemid 40175971)
53. Oxman MN, Levin MJ (2008) Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis 197(Suppl 2):S228-S236 (Pubitemid 351590176)
54. Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271-2284
55. Provost P, Krah D, Miller W et al (1989) Comparative sensitivities of assays for antibodies induced by live varicella vaccine. Interscience conference on antimicrobial agents and chemotherapy, Houston, TX
56. Provost PJ, Krah DL, Kuter BJ et al (1991) Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 9:111-116
57. Ross AH, Lencher E, Reitman G (1962) Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 267:369-376
58. Seward JF, Watson BM, Peterson CL et al (2002) Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287:606-611 (Pubitemid 34252012)
59. Son M (2008) varicella vaccine protects children with perinatal HIV infection against zoster. In: 56th Annual Meeting of IDSA. Washington, DC
60. Sutradhar SC, Wang WW, Schlienger K et al (2009) Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older. Clin Vaccine Immunol 16:646-652
61. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288-1290
62. Takahashi M, Okuno Y, Otsuka T et al (1975) Development of a live attenuated varicella vaccine. Biken J 18:25-33
63. Tseng HF, Smith N, Marcy SM, Sy LS, Jacobsen SJ (2009) Incidence of herpes zoster among children vaccinated with varicella vaccine in a prepaid health care plan in the United States, 2002-2008. Pediatr Infect Dis J 28(12):1069-1072
64. Tsolia M, Gershon A, Steinberg S, Gelb L (1990) Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 116:184-189 (Pubitemid 20056770)
65. Vazquez M, LaRussa P, Gershon A, Steinberg S, Freudigman K, Shapiro E (2001) The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 344:955-960 (Pubitemid 32240313)
66. Vazquez M, LaRussa PS, Gershon AA et al (2004) Effectiveness over time of varicella vaccine. JAMA 291:851-855 (Pubitemid 38543773)
67. Williams V, Gershon A, Brunell P (1974) Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 130:669-672
68. Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM (1992) Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 165:119-126
69. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A (2005) Impact of varicella vaccination on health care utilization. JAMA 294:797-802 (Pubitemid 41175722)